Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

5AM Solutions and LABVANTAGE Announce Partnership

Published: Sunday, February 10, 2013
Last Updated: Sunday, February 10, 2013
Bookmark and Share
Partnership to provide consulting and implementation services

5AM announced that it is partnering with LABVANTAGE Solutions, an innovative provider of enterprise laboratory informatics software. 5AM will work closely with LABVANTAGE to provide consulting and implementation services in order to support current and future LABVANTAGE customers in government organizations, commercial organizations, and academic institutions.

The partnership will initially focus on meeting increasing customer demand for training, implementation, biobanking best practices, and data standardization. 5AM’s track record of integration and implementation expertise in the domains where biospecimens play a fundamental role combined with LABVANTAGE software will provide customers the ability to fully exercise the utility of the world’s leading LIMS software faster.

“We have admired each others’ progress for years and have discovered how we can add value together,” said Erica Marrari, Biospecimen Practice Lead at 5AM Solutions. “Doing what we each do best will allow us to serve the growing market need, delivering optimal value to customers who are at the core of translating science into medical benefit.”

“As we continue to experience significant growth in the Life Science LIMS and Biobanking space, we felt it was very important for us to expand and enhance our implementation capabilities by partnering with an organization that can offer strong domain expertise and proven best practices capabilities,” said Jerry Hacker, Sr. VP of Worldwide Sales at LABVANTAGE. “We are excited about this partnership and look forward to serving our customers in a manner that meets or exceeds their expectations.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Connectome Map More Than Doubles Human Cortex’s Known Regions
Researchers at NIH have developed software that automatically detects the “fingerprint” of each of these areas in an individual’s brain scans.
Virus Inspired Cell Cargo Ships
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Identifying Cancer Drug Targets Using 3D-Modelling
Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
Human Evolution Driven by Viruses
Study finds surprising percentage of protein adaptions in humans have been driven by viruses.
Earliest Sign of Alzheimer's Development Discovered
Researchers have identified the first physiological signs of late-onset Alzheimer's disease, underlining the importance of computational power in neurology.
Computational Method Offers Significant Boost in Finding New Cancer Targets
MIT and ARIAD Pharmaceuticals team have identified evidence of significant cancer mutations.
Drug Response Predicted by Cancer Cell Lines
Large-scale study could increase success rate of developing personalised cancer treatments.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!